Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 67 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
661 15.3 months GBM Radiation
University Hospital Lausanne Switzerland 3/2005
Treatment Details: Patients: This trial involved 206 patients with glioblastoma. Demographic information on the patients was not reported. The patients were randomly divided into two groups. In addition, al
 
662 15.3 months GBM 5 Biologic therapy
Chemotherapy
Radiation
Mayo Clinic United States 10/2008
Treatment Details: Patients: This phase 1/2 study involved 97 patients with recently diagnosed glioblastoma. The median age was 57, ranging from 31 to 84 years old. About half (42) of the patients were women.
 
663 15.3 months Advanced Breast Cancer 5 Biologic therapy
PUCRS School of Medicine Brazil 3/2010
Treatment Details: Patients: This phase III trial involved women with HER2-negative advanced breast cancer that recurred following treatment with anthracycline and taxane. The study was divided into two grou
 
664 15.2 months Advanced colorectal cancer 4 Biologic therapy
Chemotherapy
Royal Marsden Hospital United Kingdom 11/2005
Treatment Details: Patients: This Phase III study involved 630 patients with previously untreated metastatic colorectal cancer. The patients were randomized into two groups. Group B had 208 patients (149 men
 
665 15.2 months Advanced colorectal cancer 4 Biologic therapy
Chemotherapy
Royal Marsden Hospital United Kingdom 11/2005
Treatment Details: Patients: This Phase III study involved 630 patients with previously untreated metastatic colorectal cancer. The patients were randomized into two groups. Group B had 208 patients (149 men
 
666 15.2 months NSCLC 5 Chemotherapy
Chinese University of Hong Kong China 7/2013
Treatment Details: Patients: This phase 3 study involved non-small cell lung cancer patients who were divided into two separate treatment groups. Group A had 226 patients with a median age of 59.0 years and
 
667 15.1 months NHL 5 Chemotherapy
Hormone
Asan Medical Center, University of Ulsan College of Medicine Korea 6/2009
Treatment Details: Patients: This phase II study involved 27 patients with non-Hodgkin’s lymphoma, 63% of whom were male. Median patient age was not given, but 41% were over the age of 60. Treatment: Pat
 
668 15.1 months Urothelial tract carcinoma 5 Biologic therapy
Chemotherapy
University of Vermont United States 6/2009
Treatment Details: Patients: This study involved 54 advanced urothelial tract carcinoma patients who had no previous chemotherapy. The median age was 63.6 years and 80% were male. Treatment: Patients wer
 
669 15.1 months Hepatocellular Carcinoma 3 Chemotherapy
University of Pittsburgh Medical Center United States 12/2014
Treatment Details: Patients: This study involved 59 hepatocellular carcinoma patients with an average age of 60.53 years; 83.1% were male. Treatment: Patients received chemotherapy with doxorubicin. Speci
 
670 15.1 months metastatic breast cancer 4 Biologic therapy
Chemotherapy
Indiana, University United States 2/2005
Treatment Details: Patients: This Phase III study involved 462 women with metastatic breast cancer. The patients were randomly divided into two groups. In Group B, there were 232 patients (mean age 51). T
 
Page 67 of 187  | Previous Page  | Next Page